Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 68, Issue 2, 2000, Pages 129-135

  Rea, T H ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DAPSONE; MINOCYCLINE; RIFAMPICIN;

ARTICLE; BORDERLINE LEPROSY; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; RELAPSE; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ANTIBIOTICS, MACROLIDE; ANTIBIOTICS, TETRACYCLINE; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; LEPROSTATIC AGENTS; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LEUKOPENIA; MALE; MINOCYCLINE; RECURRENCE; RIFAMPIN;

EID: 0033797606     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Skin pigmentation due to minocycline treatment of facial dermatoses
2. Minocycline-induced hyperpigmentation at sites of cutaneous inflammation
3. Minocycline-induced hyperpigmentation in leprosy
4. A clinical trial of minocycline in lepromatous leprosy
5. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy
6. Mycobacterium tuberculosis
7. Thalidomide in the treatment of erythema nodosum leprosum with a note on selected laboratory abnormalities in erythema nodosum leprosum
8. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen
9. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy
10. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients
11. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy
12. Field trial of efficacy of supervised monthly doses of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results
13. Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: Observations using fluorescence microscopy and high performance liquid chromatography
14. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy
15. Apparently normal skin in lepromatous leprosy
16. Lucio's phenomenon and diffuse non-nodular lepromatous leprosy
17. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum
18. Experimental and clinical studies on rifampicin in treatment of leprosy
19. Histological classification and the immunological spectrum of leprosy